case_images: PMC11757099_01
case_images: Timeline of NMOSD Treatments and Radiographically Confirmed Relapses. AZA, azathioprine; CYC, cyclophosphamide, ECU, eculizumab; MMF, mycophenolate mofetil; NMOSD, neuromyelitis optica spectrum disorder; RTX, rituximab; SAT, satralizumab. aLength of bar indicates time from symptom onset to data cutoff. bPatient received AZA for a brief period; the exact duration and timing are unknown. cExact date of discontinuation of ECU unknown. Patient had 4 months of interrupted SAT treatment due to insurance issues; exact timing of interruption unknown. dPatient received AZA with long-term corticosteroid taper. Patient died due to stage IV cervical cancer 2 months after last dose of SAT.
case_images: fimmu-15-1526563-g001.jpg
case_images: PMC11757099_02_fimmu-15-1526563-g001.jpg
case_images: f1
case_images: Patients 1, 2, 3, and 4 had >=1 radiographically confirmed relapse before receiving eculizumab ( Figure 1 ).
case_images: PMC11757099_02
case_images: Timeline of NMOSD Treatments and Radiographically Confirmed Relapses. AZA, azathioprine; CYC, cyclophosphamide, ECU, eculizumab; MMF, mycophenolate mofetil; NMOSD, neuromyelitis optica spectrum disorder; RTX, rituximab; SAT, satralizumab. aLength of bar indicates time from symptom onset to data cutoff. bPatient received AZA for a brief period; the exact duration and timing are unknown. cExact date of discontinuation of ECU unknown. Patient had 4 months of interrupted SAT treatment due to insurance issues; exact timing of interruption unknown. dPatient received AZA with long-term corticosteroid taper. Patient died due to stage IV cervical cancer 2 months after last dose of SAT.
case_images: fimmu-15-1526563-g001.jpg
case_images: PMC11757099_02_fimmu-15-1526563-g001.jpg
case_images: f1
case_images: Patients 1, 2, 3, and 4 had >=1 radiographically confirmed relapse before receiving eculizumab ( Figure 1 ).
case_images: PMC11757099_03